Education around deprescribing: 'spread and embed' the story so far.
作者信息
Poots Alan J, Jubraj Barry, Barnett Nina L
机构信息
NIHR CLAHRC Northwest London, Imperial College London, London, UK.
Institute of Pharmaceutical Science, King's College London, London, UK.
出版信息
Eur J Hosp Pharm. 2017 Jan;24(1):7-9. doi: 10.1136/ejhpharm-2016-001153.
Abstract
摘要
相似文献
1
Education around deprescribing: 'spread and embed' the story so far.
Eur J Hosp Pharm. 2017 Jan;24(1):7-9. doi: 10.1136/ejhpharm-2016-001153.
2
The Role of Patient Preferences in Deprescribing.
Clin Geriatr Med. 2017 May;33(2):165-175. doi: 10.1016/j.cger.2017.01.004. Epub 2017 Feb 23.
3
A themed journal issue on deprescribing.
Eur J Hosp Pharm. 2017 Jan;24(1):1-2. doi: 10.1136/ejhpharm-2016-001118.
4
General practitioners' insight into deprescribing for the multimorbid older individual: a qualitative study.
Int J Clin Pract. 2016 Mar;70(3):261-76. doi: 10.1111/ijcp.12780.
5
Challenges and Enablers of Deprescribing: A General Practitioner Perspective.
PLoS One. 2016 Apr 19;11(4):e0151066. doi: 10.1371/journal.pone.0151066. eCollection 2016.
6
Factors influencing deprescribing for residents in Advanced Care Facilities: insights from General Practitioners in Australia and Sweden.
BMC Fam Pract. 2016 Nov 5;17(1):152. doi: 10.1186/s12875-016-0551-7.
7
A realist evaluation of patients' decisions to deprescribe in the EMPOWER trial.
BMJ Open. 2017 May 4;7(4):e015959. doi: 10.1136/bmjopen-2017-015959.
8
Barriers and Facilitators to the Deprescribing of Nonbenzodiazepine Sedative Medications Among Older Adults.
Perm J. 2018;22:17-157. doi: 10.7812/TPP/17-157.
9
Deprescribing in older adults: a new concept for nurses in administering medicines and as prescribers of medicine.
Eur J Hosp Pharm. 2017 Jan;24(1):47-50. doi: 10.1136/ejhpharm-2016-000908.
10
Deprescribing admission medication at a UK teaching hospital; a report on quantity and nature of activity.
Int J Clin Pharm. 2018 Oct;40(5):991-996. doi: 10.1007/s11096-018-0673-1. Epub 2018 Jun 20.
引用本文的文献
1
Exploring the Knowledge and Attitudes of Physicians on Polypharmacy and Deprescribing in Clinical Practice: a Cross-Sectional Study.
Maedica (Bucur). 2025 Jun;20(2):264-274. doi: 10.26574/maedica.2025.20.2.264.
2
Desprescribing antihypertensives in older people in primary care: subgroup analysis of the MINOR randomised clinical trial.
Int J Clin Pharm. 2025 Feb;47(1):53-59. doi: 10.1007/s11096-024-01805-y. Epub 2024 Nov 6.
3
What makes a multidisciplinary medication review and deprescribing intervention for older people work well in primary care? A realist review and synthesis.
BMC Geriatr. 2023 Sep 25;23(1):591. doi: 10.1186/s12877-023-04256-8.
4
Weighing the necessities and concerns of deprescribing among older ambulatory patients and primary care trainees: a qualitative study.
BMC Prim Care. 2023 Jun 30;24(1):136. doi: 10.1186/s12875-023-02084-8.
5
Unpacking the 'process of sustaining'-identifying threats to sustainability and the strategies used to address them: a longitudinal multiple case study.
Implement Sci Commun. 2023 Jun 19;4(1):68. doi: 10.1186/s43058-023-00445-z.
6
Teaching Deprescribing and Combating Polypharmacy in the Pharmacy Curriculum: Educational Recommendations from Thematic Analysis of Focus Groups.
Clin Pract. 2023 Mar 14;13(2):442-453. doi: 10.3390/clinpract13020040.
7
A Need for Benzodiazepine Deprescribing in the COVID-19 Pandemic: A Cohort Study.
Pharmacy (Basel). 2022 Sep 23;10(5):120. doi: 10.3390/pharmacy10050120.
8
Conceptualising interventions to enhance spread in complex systems: a multisite comprehensive medication review case study.
BMJ Qual Saf. 2022 Jan;31(1):31-44. doi: 10.1136/bmjqs-2020-012367. Epub 2021 May 14.
9
Education around medication review and deprescribing: a survey of medical and pharmacy students' perspectives.
Ther Adv Drug Saf. 2020 Mar 18;11:2042098620909610. doi: 10.1177/2042098620909610. eCollection 2020.
10
Deprescribing one year on: challenging the first iatrogenic epidemic.
Eur J Hosp Pharm. 2018 Mar;25(2):63-64. doi: 10.1136/ejhpharm-2017-001482. Epub 2018 Jan 27.
本文引用的文献
1
Frailty, polypharmacy and deprescribing.
Drug Ther Bull. 2016 Jun;54(6):69-72. doi: 10.1136/dtb.2016.6.0408.
2
Evaluating differently tutored groups in problem-based learning in a German dental curriculum: a mixed methods study.
BMC Med Educ. 2016 Jan 14;16:14. doi: 10.1186/s12909-015-0505-0.
3
A pilot survey of junior doctors' attitudes and awareness around medication review: time to change our educational approach?
Eur J Hosp Pharm. 2015 Jul;22(4):243-248. doi: 10.1136/ejhpharm-2015-000664. Epub 2015 Jun 3.
4
Reducing inappropriate polypharmacy: the process of deprescribing.
JAMA Intern Med. 2015 May;175(5):827-34. doi: 10.1001/jamainternmed.2015.0324.
5
Empowering Sustained Patient Safety: The Benefits of Combining Top-down and Bottom-up Approaches.
J Nurs Care Qual. 2015 Jul-Sep;30(3):240-6. doi: 10.1097/NCQ.0000000000000103.
6
Thinking through the medication list - appropriate prescribing and deprescribing in robust and frail older patients.
Aust Fam Physician. 2012 Dec;41(12):924-8.
7
Observational studies: cohort and case-control studies.
Plast Reconstr Surg. 2010 Dec;126(6):2234-2242. doi: 10.1097/PRS.0b013e3181f44abc.
8
Cohort studies: marching towards outcomes.
Lancet. 2002 Jan 26;359(9303):341-5. doi: 10.1016/S0140-6736(02)07500-1.
9
Effectiveness of problem-based learning curricula: theory, practice and paper darts.
Med Educ. 2000 Sep;34(9):721-8. doi: 10.1046/j.1365-2923.2000.00749.x.
10
Exposure measurement in cohort studies: the challenges of prospective data collection.
Epidemiol Rev. 1998;20(1):43-56. doi: 10.1093/oxfordjournals.epirev.a017971.
Zotero 插件